Levels of preexisting antibodies to the hemagglutinin of pandemic influenza A(H1N1) 2009 (hereafter pandemic H1N1) virus positively correlate with age. The impact of contemporary seasonal influenza vaccines on establishing immunity to other pandemic H1N1 proteins is unknown. We measured serum antibodies to the neuraminidase (NA) of pandemic H1N1 in adults prior to and after vaccination with seasonal trivalent inactivated influenza vaccines. Serum antibodies to pandemic H1N1 NA were observed in all age groups; however, vaccination elevated levels of pandemic H1N1 NA antibodies predominately in elderly individuals (age, ?60 years). Therefore, contemporary seasonal vaccines likely contribute to reduction of pandemic H1N1-associated disease in older individuals.
Cites: Vaccine. 2000 Aug 1;18(28):3214-2210869766
Cites: Vaccine. 2002 Aug 19;20(25-26):3165-7012163268
Cites: Vaccine. 2003 Mar 28;21(13-14):1375-8112615433
Cites: N Engl J Med. 1972 Jun 22;286(25):1329-325027388